Clinical Trials · NCT01508858
Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 21
- Start date
- Nov 2006
- Locations
- 1 site, Sweden
- Primary endpoint
- AUC of ethinylestradiol